CGT

37개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved37 programs
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD19/CD22 CAR T-Cells (CD19/CD22 CAR T-Cells)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 54Status Recruiting
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Preclinical

CD19+CD22 CAR-T (CD19+CD22 CAR-T)

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Preclinical#Popular#cell-gene-therapy+5
Trials 53Status Active
CGTLimited DatastaleThe Leukemia and Lymphoma Socie…Phase 1

CD22 CAR (CD22 CAR)

B-ALL; B-cell Non Hodgkin Lymphoma · CD22

#CD22#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 53Status Active
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 1

CD22 CAR-T (CD22 CAR-T)

Childhood Acute Lymphoblastic Leukemia · CD22

#CD22#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 53Status Active
CGTLimited DatastaleKecellitics Biotech Company LtdPhase 2

:Anti-CD22-CAR (:Anti-CD22-CAR)

Leukemia; Lymphoma · CD22

#CD22#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTLimited DatastaleInstituto de Investigación Hosp…Phase 1

Autologous CD19/CD22 CAR T cells (Autologous CD19/CD22 CAR T cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
CGTLimited DatastaleKara Lynn DavisPhase 1

Autologous CD22 CAR T (Autologous CD22 CAR T)

B Cell Lymphoma; Acute Lymphoblastic Leukemia, Pediatric · CD22

#CD22#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 30Status Active
CGTStandard DatabasestaleYake Biotechnology Ltd.Phase 2

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

B-Cell Acute Lymphoblastic Leukemia, Adult · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTLimited DatastaleNanjing IASO Biotechnology Co.,…Phase 1

anti-CD19/CD22 CAR-T cells (anti-CD19/CD22 CAR-T cells)

MRD-positive; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 28Status Active
CGTLimited DatastaleLiping DouPhase 2

CD22/CD19 Dual-Target CAR-T Cells (CD22/CD19 Dual-Target CAR-T Cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 15Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 2

Anti-CD22-CAR-transduced T cells (Anti-CD22-CAR-transduced T cells)

Leukemia; Lymphoma · CD22

#CD22#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 13Status Active
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 1

Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells (Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells)

19 and 22+ B Cell Hematologic Tumors; 19 and 20+ B Cell Hematologic Tumors · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 8Status Recruiting
CGTLimited DatastaleStephan Grupp MD PhDPhase 2

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

B-cell Acute Lymphoblastic Leukemia; B Lineage Lymphoblastic Lymphoma · CD22

#CD22#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 6Status Recruiting
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 5Status Discontinued
CGTLimited DatastaleKecellitics Biotech Company LtdPhase 2

CD19 and CD22 targeted CAR-T cells (CD19 and CD22 targeted CAR-T cells)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 3Status Active
CGTLimited DatastaleThe Leukemia and Lymphoma Socie…Phase 1

CD22CART infusion (CD22CART infusion)

Leukemia; Acute Lymphoblastic Leukemia · CD22

#CD22#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleOhio State University Comprehen…Phase 1

Autologous Anti-CD19/CD20/CD22 CAR T-cells (Autologous Anti-CD19/CD20/CD22 CAR T-cells)

Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive; Recurrent Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 2Status Recruiting
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CD19/CD22 Chimeric Antigen Receptor T-cells (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

CD19 Positive; CD22 Positive · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Discontinued
CGTLimited DatastaleSumithira VasuPhase 1

Anti-CD19/CD20/CD22 CAR T-Cells (Anti-CD19/CD20/CD22 CAR T-Cells)

Recurrent Acute Lymphoblastic Leukemia; Recurrent B Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

Autologous CD19/CD22 dual-target CAR-T module (Autologous CD19/CD22 dual-target CAR-T module)

Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia; Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

1 / 2 pages

← PreviousNext →